Document:

Exhibit
10.1 

 

THIS
NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN
ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF
UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH
REGISTRATION IS NOT REQUIRED. 

P
R O M I S S O R Y   N O T E

 

	Principal
    Amount: $300,000	Dated as
    of December 19, 2018

 

Health
Sciences Acquisition Corporation, a Delaware corporation (the “Maker”), promises to pay to the order of Health
Sciences Holdings, LLC or its registered assigns or successors in interest (the “Payee”) the principal sum
of 300,000 dollars ($300,000) in lawful money of the United States of America, on the terms and conditions described below. All
payments on this Promissory Note (this “Note”) shall be made by check or wire transfer of immediately available
funds or as otherwise determined by the Maker to such account as the Payee may from time to time designate by written notice in
accordance with the provisions of this Note.

 

		1.	Principal.
                                         The principal balance of this Note shall be payable promptly after the date on which
                                         the Maker consummates an initial public offering of its securities or the date on which
                                         the Maker determines not to conduct an initial public offering of its securities. The
                                         principal balance may be prepaid at any time.

 

		2.	Interest.
                                         No interest shall accrue on the unpaid principal balance of this Note.

 

		3.	Application
                                         of Payments. All payments shall be applied first to payment in full of any costs
                                         incurred in the collection of any sum due under this Note, including (without limitation)
                                         reasonable attorney’s fees, then to the payment in full of any late charges and
                                         finally to the reduction of the unpaid principal balance of this Note.

 

		4.	Events
of Default. The following shall constitute an event of default (“Event of Default”):

 

		(a)	Failure
to Make Required Payments. Failure by Maker to pay the principal of this Note within five (5) business days following the
date when due.

 

		(b)	Voluntary
Liquidation, Etc. The commencement by Maker of a proceeding relating to its bankruptcy, insolvency, reorganization, rehabilitation
or other similar action, or the consent by it to the appointment of, or taking possession by, a receiver, liquidator, assignee,
trustee, custodian, sequestrator (or other similar official) for Maker or for any substantial part of its property, or the making
by it of any assignment for the benefit of creditors, or the failure of Maker generally to pay its debts as such debts become
due, or the taking of corporate action by Maker in furtherance of any of the foregoing.

 

     

     

    

 

		(c)	Involuntary
Bankruptcy, Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of maker
in an involuntary case under any applicable bankruptcy, insolvency or similar law, for the appointing of a receiver, liquidator,
assignee, custodian, trustee, sequestrator (or similar official) for Maker or for any substantial part of its property, or ordering
the winding-up or liquidation of the affairs of Maker, and the continuance of any such decree or order unstayed and in effect
for a period of 60 consecutive days.

 

		5.	Remedies.

 

		(a)	Upon
the occurrence of an Event of Default specified in Section 4(a) hereof, Payee may, by written notice to Maker, declare this Note
to be due immediately and payable, whereupon the unpaid principal amount of this Note, and all other amounts payable thereunder,
shall become immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby
expressly waived, anything contained herein or in the documents evidencing the same to the contrary notwithstanding.

 

		(b)	Upon
the occurrence of an Event of Default specified in Sections 4(b) and 4(c), the unpaid principal balance of this Note, and all
other sums payable with regard to this Note, shall automatically and immediately become due and payable, in all cases without
any action on the part of Payee.

 

		6.	Waivers.
                                         Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment
                                         for payment, demand, notice of dishonor, protest, and notice of protest with regard to
                                         the Note, all errors, defects and imperfections in any proceedings instituted by Payee
                                         under the terms of this Note, and all benefits that might accrue to Maker by virtue of
                                         any present or future laws exempting any property, real or personal, or any part of the
                                         proceeds arising from any sale of any such property, from attachment, levy or sale under
                                         execution, or providing for any stay of execution, exemption from civil process, or extension
                                         of time for payment; and Maker agrees that any real estate that may be levied upon pursuant
                                         to a judgment obtained by virtue hereof, on any writ of execution issued hereon, may
                                         be sold upon any such writ in whole or in part in any order desired by Payee.

 

		7.	Unconditional
                                         Liability. Maker hereby waives all notices in connection with the delivery, acceptance,
                                         performance, default, or enforcement of the payment of this Note, and agrees that its
                                         liability shall be unconditional, without regard to the liability of any other party,
                                         and shall not be affected in any manner by any indulgence, extension of time, renewal,
                                         waiver or modification granted or consented to by Payee, and consents to any and all
                                         extensions of time, renewals, waivers, or modifications that may be granted by Payee
                                         with respect to the payment or other provisions of this Note, and agrees that additional
                                         makers, endorsers, guarantors, or sureties may become parties hereto without notice to
                                         Maker or affecting Maker’s liability hereunder.

 

    2 

     

    

 

		8.	Notices.
                                         Any notice called for hereunder shall be deemed properly given if (a) sent by certified
                                         mail, return receipt requested, (b) personally delivered, (c) dispatched by any form
                                         of private or governmental express mail or delivery service providing receipted delivery
                                         or (d) sent by facsimile, to the following addresses or to such other address as either
                                         party may designate by notice in accordance with this Section: 

 

If to Maker:

 

Health
Sciences Acquisition Corporation

412 W 15th Street, Floor 9

New York, NY 10011

Attn: Naveen Yalamanchi, M.D.

Fax: 646-597-6998

 

If to Payee:

 

Health Sciences Holdings, LLC

412 W 15th Street, Floor 9

New York, NY 10011

Attn: Naveen Yalamanchi, M.D.

Fax: 646-597-6998

 

Notice
shall be deemed given on the earlier of (i) actual receipt by the receiving party, (ii) the date shown on a facsimile transmission
confirmation, (iii) the date reflected on a signed delivery receipt, or (iv) two (2) Business Days following tender of delivery
or dispatch by express mail or delivery service.

 

		9.	Construction.
THIS NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAW PROVISIONS
THEREOF.

 

		10.	Jurisdiction.
The courts of New York have exclusive jurisdiction to settle any dispute arising out of or in connection with this agreement
(including a dispute relating to any non-contractual obligations arising out of or in connection with this agreement) and the
parties submit to the exclusive jurisdiction of the courts of New York.

 

		11.	Severability.
Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction,
be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and
any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any
other jurisdiction.

 

		12.	Trust
Waiver. Notwithstanding anything herein to the contrary, the Payee hereby waives any and all right, title, interest or claim
of any kind (“Claim”) in or to any amounts contained in the trust account in which the proceeds of the initial
public offering (the “IPO”) conducted by the Maker and the proceeds of the sale of securities in a private
placement to occur prior to the effectiveness of the IPO, as described in greater detail in the registration statement and prospectus
to be filed with the Securities and Exchange Commission in connection with the IPO, will be placed, and hereby agrees not to seek
recourse, reimbursement, payment or satisfaction for any Claim from the trust account or any distribution therefrom for any reason
whatsoever.

 

    3 

     

    

 

		13.	Amendment;
Waiver. Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent of the
Maker and the Payee.

 

		14.	Assignment.
No assignment or transfer of this Note or any rights or obligations hereunder may be made by any party hereto (by operation
of law or otherwise) without the prior written consent of the other party hereto and any attempted assignment without the required
consent shall be void.

 

		15.	Further
Assurance. The Maker shall, at its own cost and expense, execute and do (or procure to be executed and done by any other necessary
party) all such deeds, documents, acts and things as the Payee may from time to time require as may be necessary to give full
effect to this Promissory Note.

 

(Signature
page to follow)

 

    4 

     

    

 

 IN
WITNESS WHEREOF, the Maker, intending to be legally bound hereby, has caused this Note to be duly executed on the  day and
year first above written.

 

	 	HEALTH SCIENCES ACQUISITION CORPORATION
	 	 	 
	 	By:	
	 	 	Name:	Alice lee
	 	 	Title:	Secretary and Treasurer

 

    5Exhibit
10.2

 

[●],
2019

 

Health
Sciences Acquisitions Corporation

412 West 15th Street, Floor 9

New York, New York 10011

 

Chardan
Capital Markets LLC

17 State Street

New York, NY 10004

 

Re:
Initial Public Offering

 

Ladies
and Gentlemen:

 

This
letter (the “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement
(the “Underwriting Agreement”) entered into by and between Health Sciences Acquisitions Corporation,
a Delaware corporation (the “Company”) and Chardan Capital Markets LLC (the “Representative”),
relating to an underwritten initial public offering (the “IPO”) of the Company’s units (the “Units”),
each Unit comprised of one share of common stock of the Company, par value $0.0001 per share (the “Common Stock”),
and one redeemable warrant, each whole warrant exercisable for one-half of one share of Common Stock (each, a “Warrant”).
Certain capitalized terms used herein are defined in paragraph 13 hereof.

 

In
order to induce the Company and the Representative to enter into the Underwriting Agreement and to proceed with the IPO, and in
recognition of the benefit that such IPO will confer upon the undersigned, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the undersigned hereby agrees with the Company as follows:

 

		1.	If
                                         the Company solicits approval of its shareholders of a Business Combination, the undersigned
                                         will vote all shares beneficially owned by him or her, whether acquired before, in or
                                         after the IPO, in favor of such Business Combination.

 

		2.	In
                                         the event that the Company fails to consummate a Business Combination within the time
                                         period set forth in the Company’s amended and restated certificate of incorporation,
                                         as the same may be further amended from time to time (the “Charter”),
                                         the undersigned will, as promptly as possible, take all necessary actions to cause the
                                         Company to (i) cease all operations except for the purpose of winding up, (ii) as promptly
                                         as reasonably possible, but not more than 10 business days thereafter, redeem the IPO
                                         Shares, at a per-share price, payable in cash, equal to the aggregate amount then on
                                         deposit in the Trust Account, including interest earned on the Trust Account not previously
                                         released to the Company (less taxes payable), divided by the number of then outstanding
                                         IPO Shares, which redemption will completely extinguish public shareholders’ rights
                                         as shareholders (including the right to receive further liquidation distributions, if
                                         any), and (iii) as promptly as reasonably possible following such redemption, subject
                                         to the approval of the Company’s remaining shareholders and the Company’s
                                         board of directors, dissolve and liquidate, subject in the cases of clauses (ii) and
                                         (iii) to the Company’s obligations under Delaware law to provide for claims of
                                         creditors and other requirements of applicable law. The undersigned hereby waives any
                                         and all right, title, interest or claim of any kind in or to any distribution of the
                                         Trust Account and any remaining net assets of the Company as a result of such liquidation
                                         with respect to the Founder Shares owned by the undersigned. However, if any of the undersigned
                                         have acquired IPO Shares in or after the IPO, they will be entitled to liquidating distributions
                                         from the Trust Account with respect to such IPO Shares in the event that the Company
                                         fails to consummate a Business Combination within the time period set forth in the Charter.
                                         The undersigned acknowledges and agrees that there will be no distribution from the Trust
                                         Account with respect to any Warrants, all rights of which will terminate on the Company’s
                                         liquidation.

 

     

     

    

 

 

		3.	The
                                         undersigned acknowledges and agrees that prior to entering into a definitive agreement
                                         for a Business Combination with a target business that is affiliated with the undersigned
                                         or any other Insiders of the Company or their affiliates, such transaction must be approved
                                         by a majority of the Company’s disinterested independent directors and the Company
                                         must obtain an opinion from an independent investment banking firm, which is a member
                                         of the Financial Industry Regulatory Authority, or an independent accounting firm that
                                         such Business Combination is fair to the Company’s unaffiliated shareholders from
                                         a financial point of view.

 

		4.	None
                                         of the undersigned, any member of the family of any of the undersigned, or any affiliate
                                         of the undersigned will be entitled to receive and will not accept any compensation or
                                         other cash payment prior to, or for services rendered in order to effectuate, the consummation
                                         of the Business Combination; provided that the Company shall be allowed to make the payments
                                         set forth in the Registration Statement adjacent to the caption “Prospectus Summary—The
                                         Offering—Limited payments to insiders.”

 

		5.	[In
                                         the event of the liquidation of the Trust Fund, the undersigned agrees to indemnify and
                                         hold harmless the Company against any and all loss, liability, claims, damage and expense
                                         whatsoever (including, but not limited to, any and all legal or other expenses reasonably
                                         incurred in investigating, preparing or defending against any litigation, whether pending
                                         or threatened, or any claim whatsoever) which the Company may become subject as a result
                                         of any claim by any target business or vendor or other person who is owed money by the
                                         Company for services rendered or products sold or contracted for, but only to the extent
                                         necessary to ensure that such loss, liability, claim, damage or expense does not reduce
                                         the amount of funds in the Trust Fund; provided that such indemnity shall not
                                         apply if such target business, vendor or other person has executed an agreement waiving
                                         any claims against the Trust Fund.]1

 

		(a)	The
                                         undersigned agrees that the Founder Shares may not be transferred, assigned or sold (except
                                         to certain permitted transferees as described in the Registration Statement or herein)
                                         (the “Lockup”) until the earlier to occur of: (1) six (6) months
                                         after the completion of a Business Combination or (2) the date following the completion
                                         of the Company’s initial Business Combination on which the Company completes a
                                         liquidation, merger, share exchange, reorganization or other similar transaction that
                                         results in all of the Company’s shareholders having the right to exchange their
                                         shares of Common Stock for cash, securities or other property. Notwithstanding the foregoing,
                                         if the closing price of the Company’s Common Stock equals or exceeds $12.50 per
                                         share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations
                                         and the like) for any 20 trading days within any 30-trading day period commencing at
                                         least 150 days after the Company’s initial Business Combination, 50% of the Founder
                                         Shares will be released from the Lockup.

 

		(b)	The
                                         undersigned will not, without the prior written consent of the Representative pursuant
                                         to the Underwriting Agreement, offer, sell, contract to sell, pledge, hedge or otherwise
                                         dispose of (or enter into any transaction that is designed to, or might reasonably be
                                         expected to, result in the disposition (whether by actual disposition or effective economic
                                         disposition due to cash settlement or otherwise) by the undersigned or any affiliate
                                         of the undersigned or any person in privity with the undersigned or any affiliate of
                                         the undersigned), directly or indirectly, including the filing (or participation in the
                                         filing) of a registration statement with the Securities and Exchange Commission in respect
                                         of, or establish or increase a put equivalent position or liquidate or decrease a call
                                         equivalent position within the meaning of Section 16 of the Securities Exchange Act of
                                         1934, as amended, and the rules and regulations of the Securities and Exchange Commission
                                         promulgated thereunder with respect to, any other Units, Common Stock or Warrants of
                                         the Company or any securities convertible into, or exercisable, or exchangeable for,
                                         shares of Common Stock or publicly announce an intention to effect any such transaction,
                                         for a period of 180 days after the date of the Underwriting Agreement.

 

 

1
Language only for Sponsor Insider Letter

 

    2 

     

    

 

		(c)	The
                                         undersigned agrees that until the Company consummates an initial Business Combination,
                                         the undersigned’s Private Placement Warrants will be subject to the transfer restrictions
                                         described in the Private Placement Warrants Purchase Agreement relating to the undersigned’s
                                         Private Placement Warrants.

 

		(d)	Notwithstanding
                                         the provisions set forth in paragraphs 6(a) and (c), transfers, assignments and sales
                                         (a “Transfer”) by the undersigned of the Founder Shares, Private
                                         Placement Warrants and Common Stock issued or issuable upon the exercise of the Private
                                         Placement Warrants or conversion of the Founder Shares are permitted if the Transfer
                                         (i) is among the insiders, to the Company’s officers, directors, advisors or employees;
                                         (ii) is to an Insider’s affiliates or its members upon liquidation; (iii) is to
                                         relatives and trusts for estate planning purposes; (iv) is by virtue of the law of descent
                                         and distribution upon death; (v) is pursuant to a qualified domestic relations order;
                                         (vi) involves a private sale made at a price no greater than the price at which the Founder
                                         Shares, Private Placement Warrants or Common Stock were originally purchased; or (vii)
                                         is to the Company for cancellation in connection with the consummation of the Business
                                         Combination, in each case (except for clause (vii)) where the transferee agrees to the
                                         terms of the escrow agreement and forfeiture, as the case may be, as well as the other
                                         applicable restrictions and agreements of the holders of the Founder Shares.

 

		(e)	The
                                         undersigned acknowledges and agrees that if, in order to consummate any Business Combination,
                                         the holders of Founder Shares or Private Placement Warrants are required to contribute
                                         back to the capital of the Company a portion of any such securities to be cancelled by
                                         the Company or transfer any such securities to third parties, the undersigned will contribute
                                         back to the capital of the Company or transfer to such third parties, at no cost, a proportionate
                                         number of Founder Shares or Private Placement Warrants, as applicable, pro rata with
                                         the other holders of Founder Shares or Private Placement Warrants, as applicable.

 

		6.	

 

		(a)	In
                                         order to minimize potential conflicts of interest that may arise from multiple corporate
                                         affiliations, the undersigned hereby agrees that until the earliest of the Company’s
                                         initial Business Combination or liquidation, the undersigned shall present to the Company
                                         for its consideration, prior to presentation to any other entity, any target business
                                         that has a fair market value of at least 80% of the assets held in the Trust Account
                                         (excluding the amount of deferred underwriting discounts held in trust and taxes payable
                                         on the interest earned on the trust account), subject to any existing or future fiduciary
                                         or contractual obligations the undersigned might have.

 

		(b)	The
                                         undersigned hereby agrees and acknowledges that (i) the Representative and the Company
                                         would be irreparably injured in the event of a breach of the obligations under paragraph
                                         6(a) above, (ii) monetary damages may not be an adequate remedy for such breach and (iii)
                                         the non-breaching party shall be entitled to injunctive relief, in addition to any other
                                         remedy that such party may have in law or in equity, in the event of such breach.

  

 

2
Language to be removed for Sponsor Insider Letter.

 

    3 

     

    

 

		7.	[The
                                         undersigned agrees to be a [director or officer] of the Company, as applicable, until
                                         the earlier of the consummation by the Company of an initial Business Combination or
                                         the liquidation of the Company. The undersigned’s biographical information previously
                                         furnished to the Company and the Representative is true and accurate in all material
                                         respects, does not omit any material information with respect to the undersigned’s
                                         background and contains all of the information required to be disclosed pursuant to Item
                                         401 of Regulation S-K, promulgated under the Securities Act of 1933, as amended. The
                                         undersigned’s FINRA Questionnaire previously furnished to the Company and the Representative
                                         is true and accurate in all material respects.]2 The undersigned represents
                                         and warrants that:

  

		(a)	He
                                         or she is not subject to, or a respondent in, any legal action for, any injunction, cease-and-desist
                                         order or order or stipulation to desist or refrain from any act or practice relating
                                         to the offering of securities in any jurisdiction;

 

		(b)	He
                                         or she has never been convicted of or pleaded guilty to any crime (i) involving any fraud
                                         or (ii) relating to any financial transaction or handling of funds of another person,
                                         or (iii) pertaining to any dealings in any securities and he is not currently a defendant
                                         in any such criminal proceeding; and

 

		(c)	he
                                         or she has never been suspended or expelled from membership in any securities or commodities
                                         exchange or association or had a securities or commodities license or registration denied,
                                         suspended or revoked.

 

		8.	The
                                         undersigned has full right and power, without violating any agreement by which he or
                                         she is bound, to enter into this Letter Agreement and to serve as a director or officer
                                         of the Company, as applicable.

 

		9.	The
                                         undersigned hereby waives his or her right to exercise redemption rights with respect
                                         to any of the Company’s Common Stock owned or to be owned by the undersigned, directly
                                         or indirectly, whether such shares be part of the Founder Shares or IPO Shares, and agrees
                                         that he or she will not seek redemption with respect to such shares (or sell such shares
                                         to the Company in any tender offer) in connection with any vote to approve a Business
                                         Combination.

 

		10.	The
                                         undersigned hereby agrees to not propose, or vote in favor of, an amendment to Article
                                         [●] of the Charter prior to the consummation of a Business Combination unless the
                                         Company provides public shareholders with the opportunity to redeem their IPO Shares
                                         upon such approval in accordance with such Article [●] thereof.

 

		11.	The
                                         undersigned agrees not to participate in the formation of, or become an officer or director
                                         of, any other blank check company (excluding existing affiliations), until the Company
                                         has entered into a definitive agreement with respect to an initial Business Combination
                                         or the Company has failed to complete an initial Business Combination within the time
                                         period set forth in the Charter.

 

		12.	This
                                         Letter Agreement shall be governed by and construed and enforced in accordance with the
                                         laws of the State of New York, without giving effect to conflicts of law principles that
                                         would result in the application of the substantive laws of another jurisdiction. The
                                         undersigned hereby (i) agrees that any action, proceeding or claim against him arising
                                         out of or relating in any way to this Letter Agreement shall be brought and enforced
                                         in the courts of the State of New York of the United States of America for the Southern
                                         District of New York, and irrevocably submits to such jurisdiction, which jurisdiction
                                         shall be exclusive and (ii) waives any objection to such exclusive jurisdiction and that
                                         such courts represent an inconvenient forum.

 

		13.	As
                                         used herein, (i) a “Business Combination” shall mean a merger,
                                         share exchange, asset acquisition, stock purchase, recapitalization, reorganization or
                                         other similar business combination with one or more businesses or entities; (ii) “Insiders”
                                         shall mean all officers, directors and sponsors of the Company immediately prior to the
                                         IPO; (iii) “Founder Shares” shall mean the 2,875,000 shares
                                         of Common Stock of the Company acquired by the Sponsor prior to the IPO; (iv) “IPO
                                         Shares” shall mean the shares of Common Stock issued in the Company’s
                                         IPO; (v) “Private Placement Warrants” shall mean the warrants
                                         that are being sold privately by the Company simultaneously with the consummation of
                                         the IPO; (vi) “Trust Account” shall mean the trust account
                                         into which the net proceeds of the Company’s IPO and a portion of the proceeds
                                         from the sale of the Private Placement Warrants will be deposited; and (vii) “Registration
                                         Statement” means the Company’s registration statement on Form S-1
                                         (SEC File No. 333-[●]) filed with the Securities and Exchange Commission, as amended.

 

    4 

     

    

 

		14.	This
                                         Letter Agreement constitutes the entire agreement and understanding of the parties hereto
                                         in respect of the subject matter hereof and supersedes all prior understandings, agreements,
                                         or representations by or among
                                         the parties hereto, written or oral, to the extent they relate in any way to the subject
                                         matter hereof or the transactions contemplated hereby. This Letter Agreement may not
                                         be changed, amended, modified or waived (other than to correct a typographical error)
                                         as to any particular provision, except by a written instrument executed by all parties
                                         hereto.

  

		15.	The
                                         undersigned acknowledges and understands that the Representative and the Company will
                                         rely upon the agreements, representations and warranties set forth herein in proceeding
                                         with the IPO. Nothing contained herein shall be deemed to render the any Representative
                                         a representative of, or a fiduciary with respect to, the Company, its shareholders or
                                         any creditor or vendor of the Company with respect to the subject matter hereof.

 

		16.	This
                                         Letter Agreement shall be binding on the undersigned and such person’s respective
                                         successors, heirs, personal representatives and assigns. This Letter Agreement shall
                                         terminate on the earlier of (i) the consummation of a Business Combination and (ii) the
                                         liquidation of the Company; provided that such termination shall not relieve the undersigned
                                         from liability for any breach of this agreement prior to its termination. The parties
                                         hereto may not assign either this Letter Agreement or any of their rights, interests,
                                         or obligations hereunder without the prior written consent of the other party. Any purported
                                         assignment in violation of this paragraph shall be void and ineffectual and shall not
                                         operate to transfer or assign any interest or title to the purported assignee.

 

[Signature
Page Follows]

 

    5 

     

    

  

	 	Sincerely,
	 	By:	 
	 	 	Name
    of Insider:

	 	Acknowledged
    and Agreed:
	 	 
	 	Health
    Sciences Acquisitions Corporation
	 	By:	 
	 	 	Name:
	 	 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00295-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00295-of-00352.parquet"}]]